S100A1 and neoplasm: MDSCs contribute to immune suppression through the direct T-cell inhibition and recruitment of T regulatory cells, drive inflammation through the expression of S100A proteins, and promote tumor colonization by increasing vascular permeability and the induction of E-selectin expression to promote circulating tumor cell arrest and extravasation [17,18].